Cargando…

Restored expression of Fhit protein in Fhit-minus breast cancer cells

Detalles Bibliográficos
Autores principales:	Campiglio, M, Olgiati, C, Aiello, P, Croce, CM, Ménard, S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2001
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3300522/ http://dx.doi.org/10.1186/bcr339

Ejemplares similares

Analysis of Fhit expression in stages of breast cancer progression
por: Campiglio, M, et al.
Publicado: (2000)

Analysis of chromosome alterations and the E-cadherin and FHIT genes in lobular breast cancer
por: Ingvarsson, S, et al.
Publicado: (2000)

The Fhit protein: an opportunity to overcome chemoresistance
por: Gaudio, Eugenio, et al.
Publicado: (2016)

FHIT gene and cancer.
Publicado: (1996)

Fhit loss in familial breast cancer: is loss of DNA repair function linked to alterations at chromosome fragile sites?
por: Huebner, K, et al.
Publicado: (2001)

Association of FHIT expression and FHIT gene hypermethylation with liver cancer risk: a PRISMA-compliant meta-analysis
por: Zhang, Yaping, et al.
Publicado: (2017)

FHIT Doubts are Clear Now
por: Wali, Anjilna
Publicado: (2010)

The expression of FHIT, PCNA and EGFR in benign and malignant breast lesions
por: Terry, G, et al.
Publicado: (2007)

Aberrant FHIT transcripts in hepatocellular carcinomas.
por: Chen, Y. J., et al.
Publicado: (1998)

Cancer and the FRA3B/FHIT fragile locus: it's a HIT
por: Huebner, K, et al.
Publicado: (2003)

Evaluation of FHIT gene alterations in ovarian cancer.
por: Buttitta, F., et al.
Publicado: (1998)

Alternative Splicing of the FHIT Gene in Colorectal Cancers
por: Hibi, Kenji, et al.
Publicado: (1997)

Impaired FHIT expression characterizes serous ovarian carcinoma
por: Ozaki, K, et al.
Publicado: (2001)

Fhit-deficient normal and cancer cells are mitomycin C and UVC resistant
por: Ottey, M, et al.
Publicado: (2004)

Abnormalities of the FHIT gene in human oral carcinogenesis
por: Tanimoto, K, et al.
Publicado: (2000)

Abnormalities of the FHIT Transcripts in Osteosarcoma and Ewing Sarcoma
por: Hinohara, Shin‐ichi, et al.
Publicado: (1998)

Abnormal Fhit expression is an independent poor prognostic factor for cervical cancer
por: Takizawa, S, et al.
Publicado: (2003)

Development of spontaneous tumours and intestinal lesions in Fhit gene knockout mice
por: Fujishita, T, et al.
Publicado: (2004)

Effects of FHIT gene on proliferation and apoptosis of osteosarcoma cells
por: Xu, Zhengfeng, et al.
Publicado: (2019)

Aberrant transcripts of the FHIT gene are expressed in normal and leukaemic haemopoietic cells.
por: Carapeti, M., et al.
Publicado: (1998)

Abnormal FHIT expression profiles in cervical intraepithelial neoplastic (CIN) lesions
por: Terry, G, et al.
Publicado: (2002)

Multiple Patterns of FHIT Gene Homozygous Deletion in Egyptian Breast Cancer Patients
por: Ismail, Heba M. S., et al.
Publicado: (2011)

Impact of FHIT loss on the translation of cancer-associated mRNAs
por: Kiss, Daniel L., et al.
Publicado: (2017)

Fhit loss‐associated initiation and progression of neoplasia in vitro
por: Karras, Jenna R., et al.
Publicado: (2016)

The Clinical Relevance of Fragile Histidine Triad Protein (FHIT) in Patients with Bladder Cancer
por: Liu, Xiao-Ping, et al.
Publicado: (2018)

Gene expression of WWOX, FHIT and p73 in acute lymphoblastic leukemia
por: CHEN, XU, et al.
Publicado: (2013)

Initiation of Genome Instability and Preneoplastic Processes through Loss of Fhit Expression
por: Saldivar, Joshua C., et al.
Publicado: (2012)

Adenylylsulfate–ammonia adenylyltransferase activity is another inherent property of Fhit proteins
por: Wojdyła-Mamoń, Anna M., et al.
Publicado: (2015)

FHIT as a biomarker for early screening of adult T-cell leukemia
por: Bellon, Marcia, et al.
Publicado: (2021)

Fhit–Fdxr interaction in the mitochondria: modulation of reactive oxygen species generation and apoptosis in cancer cells
por: Druck, Teresa, et al.
Publicado: (2019)

Effect of interventional embolotherapy on FHIT and p16 expression in hepatocellular carcinoma patients
por: Xu, Wei, et al.
Publicado: (2019)

Loss of fragile histidine triad (Fhit) protein expression alters the translation of cancer-associated mRNAs
por: Kiss, Daniel L., et al.
Publicado: (2018)

Tanshinones induce tumor cell apoptosis via directly targeting FHIT
por: Zhou, Xianglian, et al.
Publicado: (2021)

Expression and correlation of Bmi-1, AEG-1 and FHIT in bladder transitional cell carcinoma
por: Su, Wei, et al.
Publicado: (2020)

FHIT Suppresses Epithelial-Mesenchymal Transition (EMT) and Metastasis in Lung Cancer through Modulation of MicroRNAs
por: Suh, Sung-Suk, et al.
Publicado: (2014)

Restoration of MHC-I on Tumor Cells by Fhit Transfection Promotes Immune Rejection and Acts as an Individualized Immunotherapeutic Vaccine
por: Pulido, María, et al.
Publicado: (2020)

Overcome Chemoresistance: Biophysical and Structural Analysis of Synthetic FHIT-Derived Peptides
por: Scala, Maria Carmina, et al.
Publicado: (2021)

Reduced Fhit expression is associated with mismatch repair deficiency in human advanced colorectal carcinoma
por: Andachi, H, et al.
Publicado: (2002)

The Rosetta Stone Hypothesis-Based Interaction of the Tumor Suppressor Proteins Nit1 and Fhit
por: Mittag, Sonnhild, et al.
Publicado: (2023)

The ubiquitous ‘cancer mutational signature’ 5 occurs specifically in cancers with deleted FHIT alleles
por: Volinia, Stefano, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_a4nelpjmbhnh0vmuuopj7uonrl